Gamelin Erick 4
4 · Acrivon Therapeutics, Inc. · Filed Nov 18, 2025
Insider Transaction Report
Form 4
Gamelin Erick
Chief Development Officer
Transactions
- Tax Payment
Common Stock
2025-11-14$2.24/sh−403$903→ 15,283 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.